McGill, J. B. (2014). The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: A Bench to Bedside Review. Springer Healthcare.
Citação norma ChicagoMcGill, Janet B. The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: A Bench to Bedside Review. Springer Healthcare, 2014.
MLA CitationMcGill, Janet B. The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: A Bench to Bedside Review. Springer Healthcare, 2014.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.